Hester Biosciences Declares Q1 FY27 Unaudited Results
Hester Biosciences Ltd announced its unaudited standalone and consolidated financial results for the quarter ended 30 June 2026. The Board of Directors approved the results in a meeting held on 30 July 2026. The company reported total income of ₹2,997.71 million and a profit after tax of ₹521.00 million for the quarter. The results also include segment-wise performance for Poultry Healthcare and Animal Healthcare, with Poultry Healthcare contributing ₹618.16 million in revenue and ₹245.19 million in segment results for the quarter. The company will publish extracts of the results in newspapers as per SEBI regulations.
Key Highlights
- Q1 FY27 consolidated revenue at ₹2,997.71 million.
- Q1 FY27 profit after tax reported at ₹521.00 million.
- Poultry Healthcare segment leads revenue with ₹618.16 million.
- Board meeting held on July 30, 2026, approved the results.
- Basic EPS for the quarter stands at ₹61.24.
Price Impact
More from HESTERBIO
Hester Biosciences Launches Interactive Microsite for Annual Report
Hester Biosciences Q1 FY27: Standalone Revenue Up 14%, Consolidated Profit Up 459%
Hester Q1: Consol PAT +459% on one-off gain, but adjusted profit falls ~34% YoY